216 related articles for article (PubMed ID: 26677224)
1. Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy.
Künze G; Köhling S; Vogel A; Rademann J; Huster D
J Biol Chem; 2016 Feb; 291(6):3100-13. PubMed ID: 26677224
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a glycosaminoglycan binding site on interleukin-10 via molecular simulation methods.
Gehrcke JP; Pisabarro MT
J Mol Graph Model; 2015 Nov; 62():97-104. PubMed ID: 26409190
[TBL] [Abstract][Full Text] [Related]
3. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
Joseph PR; Mosier PD; Desai UR; Rajarathnam K
Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the structure of regulatory proteins interacting with glycosaminoglycans by combining NMR spectroscopy and molecular modeling - the beginning of a wonderful friendship.
Künze G; Huster D; Samsonov SA
Biol Chem; 2021 Oct; 402(11):1337-1355. PubMed ID: 33882203
[TBL] [Abstract][Full Text] [Related]
5. CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.
Sepuru KM; Rajarathnam K
J Biol Chem; 2016 Feb; 291(8):4247-55. PubMed ID: 26721883
[TBL] [Abstract][Full Text] [Related]
6. NMR characterization of the binding properties and conformation of glycosaminoglycans interacting with interleukin-10.
Künze G; Gehrcke JP; Pisabarro MT; Huster D
Glycobiology; 2014 Nov; 24(11):1036-49. PubMed ID: 25002415
[TBL] [Abstract][Full Text] [Related]
7. NMR and molecular modeling reveal specificity of the interactions between CXCL14 and glycosaminoglycans.
Penk A; Baumann L; Huster D; Samsonov SA
Glycobiology; 2019 Sep; 29(10):715-725. PubMed ID: 31264681
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycan-Protein Interactions by Nuclear Magnetic Resonance (NMR) Spectroscopy.
Pomin VH; Wang X
Molecules; 2018 Sep; 23(9):. PubMed ID: 30208595
[TBL] [Abstract][Full Text] [Related]
9. Unique properties of human β-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site.
De Paula VS; Pomin VH; Valente AP
J Biol Chem; 2014 Aug; 289(33):22969-22979. PubMed ID: 24970887
[TBL] [Abstract][Full Text] [Related]
10. Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach.
Möbius K; Nordsieck K; Pichert A; Samsonov SA; Thomas L; Schiller J; Kalkhof S; Teresa Pisabarro M; Beck-Sickinger AG; Huster D
Glycobiology; 2013 Nov; 23(11):1260-9. PubMed ID: 23982278
[TBL] [Abstract][Full Text] [Related]
11. The effect of interleukin-8 truncations on its interactions with glycosaminoglycans.
Nordsieck K; Baumann L; Hintze V; Pisabarro MT; Schnabelrauch M; Beck-Sickinger AG; Samsonov SA
Biopolymers; 2018 Aug; 109(10):e23103. PubMed ID: 29377072
[TBL] [Abstract][Full Text] [Related]
12. Identification of a glycosaminoglycan binding surface on human interleukin-8.
Kuschert GS; Hoogewerf AJ; Proudfoot AE; Chung CW; Cooke RM; Hubbard RE; Wells TN; Sanderson PN
Biochemistry; 1998 Aug; 37(32):11193-201. PubMed ID: 9698365
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the heparin-binding site of the NC1 domain of collagen XIV by CD and NMR.
Montserret R; Aubert-Foucher E; McLeish MJ; Hill JM; Ficheux D; Jaquinod M; van der Rest M; Deléage G; Penin F
Biochemistry; 1999 May; 38(20):6479-88. PubMed ID: 10350466
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.
Zhao B; Liwang PJ
Biochemistry; 2010 Aug; 49(33):7012-22. PubMed ID: 20712376
[TBL] [Abstract][Full Text] [Related]
15. Docking glycosaminoglycans to proteins: analysis of solvent inclusion.
Samsonov SA; Teyra J; Pisabarro MT
J Comput Aided Mol Des; 2011 May; 25(5):477-89. PubMed ID: 21597992
[TBL] [Abstract][Full Text] [Related]
16. Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions.
Sepuru KM; Nagarajan B; Desai UR; Rajarathnam K
J Biol Chem; 2016 Sep; 291(39):20539-50. PubMed ID: 27471273
[TBL] [Abstract][Full Text] [Related]
17. Ligand binding of interleukin-8: a comparison of glycosaminoglycans and acidic peptides.
Schulze C; Danielsson A; Liwo A; Huster D; Samsonov SA; Penk A
Phys Chem Chem Phys; 2023 Sep; 25(36):24930-24947. PubMed ID: 37694394
[TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.
Rother S; Samsonov SA; Hofmann T; Blaszkiewicz J; Köhling S; Moeller S; Schnabelrauch M; Rademann J; Kalkhof S; von Bergen M; Pisabarro MT; Scharnweber D; Hintze V
Acta Biomater; 2016 Nov; 45():143-154. PubMed ID: 27545813
[TBL] [Abstract][Full Text] [Related]
20. Solution NMR Spectroscopy for Characterizing Protein-Glycosaminoglycan Interactions.
Joseph PRB; Sepuru KM; Poluri KM; Rajarathnam K
Methods Mol Biol; 2022; 2303():13-23. PubMed ID: 34626366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
